A gemcitabine-based regimen followed by autologous stem cell transplantation show high efficacy and well tolerance in malignant lymphoma

Bone Marrow Transplant. 2022 Jun;57(6):1017-1020. doi: 10.1038/s41409-022-01655-0. Epub 2022 Apr 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Deoxycytidine / analogs & derivatives
  • Etoposide / therapeutic use
  • Gemcitabine
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphoma* / drug therapy
  • Stem Cell Transplantation
  • Transplantation Conditioning
  • Transplantation, Autologous

Substances

  • Deoxycytidine
  • Etoposide
  • Gemcitabine